Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Jun 26, 2023)
Date Submitted: Apr 17, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Interpretable Deep Learning for Drug-Induced Liver Injury among Patients with Tuberculosis: Model Development and Validation Study
ABSTRACT
Background:
Drug-induced liver injury (DILI) is associated with treatment discontinuation and treatment failure in patients with tuberculosis (TB). Due to the unpredictable nature of DILI, it is increasingly becoming a threat to global TB eradication initiatives.
Objective:
This study aimed to develop and validate an interpretable prediction model for DILI during TB treatment.
Methods:
Eligible adult TB patients in Ningbo City from 2015 to 2020 were included. We used the XGBoost algorithm to predict the probability of DILI occurrence, compared with the LASSO-Logistic algorithm. HDPS method was applied for feature extraction. We assessed the performance by the stratified 10-fold cross validation and the AUROC. The SHAP value was used to interpret the XGBoost model of mild and more severe DILI patients.
Results:
We included 7,071 subjects (median age 47 years; 68.0% male). 16.3% developed DILI. The XGBoost algorithm yielded the final DILI prediction model with five main risk factors: previous history of DILI, ALP, TBL, ALT and age at TB onset. It outperformed the LASSO-Logistic model in AUROC (0.90 vs. 0.76). The SHAP value showed that older patients and higher ALP, ALT and TBL were more likely to develop more severe DILI, However, previous DILI experience is inversely related to the severity of DILI.
Conclusions:
XGBoost model demonstrated high accuracy and interpretability in predicting DILI among TB patients. Clinicians could leverage algorithmic technique and EHR data to diagnose and manage DILI during TB treatment promptly.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.